These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 37221053

  • 21. Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.
    Hinkle JT, Perepezko K, Mills KA, Mari Z, Butala A, Dawson TM, Pantelyat A, Rosenthal LS, Pontone GM.
    Parkinsonism Relat Disord; 2018 Oct; 55():8-14. PubMed ID: 30146185
    [Abstract] [Full Text] [Related]

  • 22. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease.
    Muñoz-Delgado L, Labrador-Espinosa MÁ, Macías-García D, Jesús S, Benítez Zamora B, Fernández-Rodríguez P, Adarmes-Gómez AD, Reina Castillo MI, Castro-Labrador S, Silva-Rodríguez J, Carrillo F, García Solís D, Grothe MJ, Mir P.
    Mov Disord; 2023 May; 38(5):755-763. PubMed ID: 36912400
    [Abstract] [Full Text] [Related]

  • 23. Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
    Kim H, Oh M, Oh JS, Moon H, Chung SJ, Lee CS, Kim JS.
    Nucl Med Commun; 2019 Dec; 40(12):1216-1223. PubMed ID: 31584466
    [Abstract] [Full Text] [Related]

  • 24. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
    Le Heron C, Plant O, Manohar S, Ang YS, Jackson M, Lennox G, Hu MT, Husain M.
    Brain; 2018 May 01; 141(5):1455-1469. PubMed ID: 29672668
    [Abstract] [Full Text] [Related]

  • 25. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.
    Erro R, Pappatà S, Amboni M, Vicidomini C, Longo K, Santangelo G, Picillo M, Vitale C, Moccia M, Giordano F, Brunetti A, Pellecchia MT, Salvatore M, Barone P.
    Parkinsonism Relat Disord; 2012 Nov 01; 18(9):1034-8. PubMed ID: 22789824
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson's Disease.
    Bayram E, Kaplan N, Shan G, Caldwell JZK.
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2020 Jul 01; 27(4):581-594. PubMed ID: 31411534
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W.
    Mov Disord; 2003 Oct 01; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.
    Simuni T, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun D, Poston K, Arnedo V, Frasier M, Sherer T, Chowdhury S, Marek K, Parkinson's Progression Marker Initiative*.
    Mov Disord; 2018 May 01; 33(5):771-782. PubMed ID: 29572948
    [Abstract] [Full Text] [Related]

  • 35. Relation of overactive bladder with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
    Mito Y, Yabe I, Yaguchi H, Takei T, Terae S, Tajima Y.
    Parkinsonism Relat Disord; 2018 May 01; 50():37-41. PubMed ID: 29449184
    [Abstract] [Full Text] [Related]

  • 36. Survival in Parkinson's disease in relation to striatal dopamine transporter binding.
    Mäkinen E, Joutsa J, Vahlberg T, Kaasinen V.
    Parkinsonism Relat Disord; 2017 Sep 01; 42():66-72. PubMed ID: 28662820
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Combined use of dopamine transporter imaging (DAT-SPECT) and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease.
    Yoshii F, Ryo M, Baba Y, Koide T, Hashimoto J.
    J Neurol Sci; 2017 Apr 15; 375():80-85. PubMed ID: 28320195
    [Abstract] [Full Text] [Related]

  • 39. Association of choroid plexus volume with motor symptoms and dopaminergic degeneration in Parkinson's disease.
    Jeong SH, Park CJ, Jeong HJ, Sunwoo MK, Ahn SS, Lee SK, Lee PH, Kim YJ, Sohn YH, Chung SJ.
    J Neurol Neurosurg Psychiatry; 2023 Dec 15; 94(12):1047-1055. PubMed ID: 37399288
    [Abstract] [Full Text] [Related]

  • 40. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
    Navalpotro-Gomez I, Dacosta-Aguayo R, Molinet-Dronda F, Martin-Bastida A, Botas-Peñin A, Jimenez-Urbieta H, Delgado-Alvarado M, Gago B, Quiroga-Varela A, Rodriguez-Oroz MC.
    Eur J Nucl Med Mol Imaging; 2019 Sep 15; 46(10):2065-2076. PubMed ID: 31273436
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.